ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.080
+0.380 (10.27%)
Aug 27, 2026, 4:08 PM HKT
-65.42% (1Y)
| Market Cap | 1.60B -68.2% |
| Revenue (ttm) | 145.47M +2.6% |
| Net Income | -265.74M |
| EPS | -0.63 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,989,200 |
| Open | 3.755 |
| Previous Close | 3.700 |
| Day's Range | 3.665 - 4.180 |
| 52-Week Range | 2.800 - 16.800 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |